Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/0512 stock hub

HKG/0512 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/0512is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.5B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/0512

In the news

Latest news · HKG/0512

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.4

P25 11.7P50 18.9P75 41.4

Trailing P/E17.4

P25 10.7P50 17.9P75 38.5

ROE7.4

P25 -14.7P50 2P75 9.4

ROIC8.2

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/0512 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

HKD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Bermuda
Country code	HK
Employees	12,614
Employees Change	627%
Employees Change Percent	5.23
Enterprise value	HKD 22.5B
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	BMG210A71016
Last refreshed	2026-05-10
Market cap	HKD 21.5B
Price	HKD 6.15
Price currency	HKD
Rev Per Employee	973,780.8x
Sector	Healthcare
Sic	2834
Symbol	hkg/0512
Website	https://www.grandpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.76%
EV Earnings	18.13x
EV/EBIT	12.21x
EV/EBITDA	9.28x
EV/FCF	24.36x
EV/Sales	1.83x
FCF yield	4.29%
Forward P/E	13.37x
P/B ratio	1.25x
P/E ratio	17.36x
P/S ratio	1.75x
PE Ratio10 Y	9.62x
PE Ratio3 Y	13.06x
PE Ratio5 Y	10.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.38%
EBITDA Margin	18.8%
FCF margin	7.52%
Gross margin	55.2%
Gross Profit	HKD 6.8B
Gross Profit Growth	0.49%
Gross Profit Growth Q	1.05%
Gross Profit Growth3 Y	2.77%
Gross Profit Growth5 Y	0.66%
Net Income	HKD 1.2B
Net Income Growth	-49.73%
Net Income Growth Q	-92.11%
Net Income Growth Years	0%
Net Income Growth3 Y	-19.83%
Net Income Growth5 Y	-12.35%
Pretax Margin	12.16%
Profit Margin	10.1%
Profit Per Employee	HKD 98,373
Profitable Years	17
ROA	4.23
Roa5y	6.62
ROCE	8.9
ROE	7.38
Roe5y	14.07
ROIC	8.19
Roic5y	13.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.39%
Cagr15y	19.28%
Cagr1y	-9.43%
Cagr20y	24.35%
Cagr3y	9.41%
Cagr5y	2%
Div CAGR10	6.99%
Div CAGR3	6.48%
Div CAGR5	8.97%
EPS Growth	-49.73
EPS Growth Q	-92.12
EPS Growth Years	0
EPS Growth3 Y	-19.89
EPS Growth5 Y	-12.12
FCF Growth	-31.21%
FCF Growth Q	-20.06%
FCF Growth3 Y	-13.97%
FCF Growth5 Y	-2.28%
OCF Growth	-13.1%
OCF Growth Q	-5.84%
OCF Growth10 Y	1.26%
OCF Growth3 Y	-4.65%
OCF Growth5 Y	-1.77%
Revenue Growth	5.48x
Revenue Growth Q	10.33x
Revenue Growth Quarters	11x
Revenue Growth Years	5x
Revenue Growth3 Y	5.08x
Revenue Growth5 Y	3.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.47
Assets	HKD 27.2B
Cash	HKD 3.9B
Current Assets	HKD 8.3B
Current Liabilities	HKD 7.3B
Debt	HKD 4.7B
Debt EBITDA	HKD 2.01
Debt Equity	HKD 0.28
Debt FCF	HKD 5.12
Equity	HKD 17.2B
Interest Coverage	10.88
Liabilities	HKD 10B
Long Term Assets	HKD 18.9B
Long Term Liabilities	HKD 2.7B
Net Cash	HKD -797.4M
Net Cash By Market Cap	HKD -3.7
Net Debt EBITDA	HKD 0.35
Net Debt Equity	HKD 0.05
Net Debt FCF	HKD 0.86
Tangible Book Value	HKD 12.1B
Tangible Book Value Per Share	HKD 3.45
WACC	7.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.14
Inventory Turnover	3.86
Net Working Capital	HKD -92.8M
Quick ratio	0.93
Working Capital	HKD 990.8M
Working Capital Turnover	HKD 10.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-35%
Dividend Growth Years	0%
Dividend per share	HKD 0.17
Dividend Years	8
Dividend Yield	2.75%
Ex Div Date	2026-06-12
Last Dividend	HKD 0.17
Payout Frequency	Annual
Payout Ratio	73.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	396.75%
1Y total return	-9.43%
200-day SMA	8.03
3Y total return	30.98%
50-day SMA	6.89
50-day SMA vs 200-day SMA	50under200
5Y total return	10.38%
All Time High	11.43
All Time High Change	-46.17%
All Time High Date	1996-03-05
All Time Low	0.07
All Time Low Change	8,736.21%
All Time Low Date	2004-07-27
ATR	0.21
Beta	0.74
Beta1y	0.71
Beta2y	0.34
Ch YTD	-21.66
High	6.15
High52	10.2
High52 Date	2025-06-12
High52ch	-39.71%
Low	6.08
Low52	6.01
Low52 Date	2026-05-05
Low52ch	2.33%
Ma50ch	-10.69%
Price vs 200-day SMA	-23.41%
RSI	33.54
RSI Monthly	46.09
RSI Weekly	26.9
Sharpe ratio	0.18x
Sortino ratio	0.45
Total Return	2.75%
Tr YTD	-21.66
Tr15y	1,307.45%
Tr1m	-14.82%
Tr1w	-1.13%
Tr3m	-22.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 1.8B
Operating Income Growth	-9.92
Operating Income Growth Q	-25.41
Operating Income Growth3 Y	-16.54
Operating Income Growth5 Y	-7.46
Operating margin	14.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,255,945,266%
Net Borrowing	116,269,000
Shares Insiders	55.39%
Shares Institutions	12.17%
Shares Out	3,501,809,648
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 923.4M
Average Volume	4,543,327.25x
Bv Per Share	4.86
CAPEX	HKD -726.2M
Ch10y	302
Ch15y	1,038.9
Ch1m	-14.82
Ch1w	-1.13
Ch1y	-9.43
Ch20y	5,989.1
Ch3m	-22.05
Ch3y	15.17
Ch5y	-6.82
Ch6m	-26.96
Change	0.65%
Change From Open	0.82
Close	6.11
Days Gap	-0.16
Depreciation Amortization	542,837,000
Dollar Volume	35,205,207.6
Earnings Date	2026-05-19
EBIT	HKD 1.8B
EBITDA	HKD 2.3B
EPS	HKD 0.35
F Score	5
FCF	HKD 923.4M
FCF EV Yield	4.1x
FCF Per Share	HKD 0.26
Financing CF	-951,541,000
Fiscal Year End	December
Founded	1,995
Goodwill	1,676,875,000
Graham Number	6.22449
Graham Upside	1.21
Income Tax	HKD 249.8M
Investing CF	-967,515,000
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Date	2004-04-27
Last Split Type	Reverse
Lynch Fair Value	HKD 1.77
Lynch Upside	-71.19
Ma150	7.72
Ma150ch	-20.3%
Ma20	6.46
Ma20ch	-4.81%
Net CF	-198,609,000
Next Earnings Date	2026-05-19
Open	6.1
P FCF Ratio	23.32
P OCF Ratio	13.06
Payment Date	2026-06-30
Position In Range	100
Ppne	4,824,497,000
Price Date	2026-05-08
Price EBITDA	HKD 9.32
Ptbv Ratio	1.78
Relative Volume	1.26x
Revenue	12,283,271,000x
Tax By Revenue	2.03x
Tax Rate	16.72%
Tr20y	7,712.2%
Tr6m	-26.96%
Volume	5,724,424
Z Score	2.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/0512 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$0.17 annual per share

Payout ratio

+73.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.0%

0 consecutive years of growth

Total shareholder yield

+2.7%

Next ex-dividend date: 2026-06-12

Performance

HKG/0512 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/0512?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.2%

Share of float held by funds and institutions

Insider ownership

+55.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/0512 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.5

Neutral momentum band

Price vs 200-day MA

-23.4%

50/200-day relationship not available

Beta (5Y)

0.74

Less volatile than the market

Sharpe ratio

0.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/0512

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/0512 stock rating?

hkg/0512 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/0512 analysis?

The full report lives at /stocks/hkg/0512/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/0512?

The latest report frames hkg/0512 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/0512 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.